Literature DB >> 8912673

Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

T M Hackeng1, G Tans, S J Koppelman, P G de Groot, J Rosing, B N Bouma.   

Abstract

The conversion of protein C into activated protein C (APC) by the thrombin-thrombomodulin complex on the surface of endothelial cells initiates an essential negative feedback reaction on blood coagulation. APC, together with its non-enzymic cofactor protein S, inactivates factors Va and VIIIa, the non-enzymic protein cofactors of the prothrombinase and intrinsic tenase complex, by proteolytic degradation. In this study we report that prothrombin activation products, generated by the prothrombinase complex on the surface of quiescent endothelial cells, are able to activate protein C. Subsequent inactivation of factor Va by the APC that was formed decreased the rate of prothrombin activation, thus demonstrating in vitro the negative feedback loop on coagulation factor activation. The anticoagulant feedback reaction of APC on the prothrombinase complex was stimulated 3-4-fold by the addition of protein S but not by thrombin-cleaved protein S or by protein S complexed with C4b-binding protein. Stimulation of endothelial cells with 50 pM tumour necrosis factor (TNF) or 500 pM interleukin 1 (IL-1) resulted in a 70% decrease in activation of protein C by exogenously added alpha-thrombin, which seemed to be due to down-regulation of thrombomodulin activity on the surface of endothelial cells. However, when prothrombin activation products generated in situ were allowed to activate protein C, stimulation of endothelial cells with TNF and IL-1 resulted in only a 25% decrease in activation of protein C. Stimulation with TNF or IL-1 did not affect the ability of endothelial cells to support prothrombinase activity. We investigated whether the differences in extent of protein C activation by exogenously added alpha-thrombin and by prothrombin activation products generated in situ were due to meizothrombin formed during prothrombin activation. Previous reports from our groups revealed that meizothrombin is generated as a transient intermediate during prothrombin activation on phospholipid vesicles and endothelial cells. Here we show that meizothrombin is at least a 6-fold better activator of protein C on the surface of endothelial cells than is alpha-thrombin. These results demonstrate that meizothrombin, formed during the initial phase of prothrombin activation, efficiently down-regulates both its own formation and that of thrombin.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912673      PMCID: PMC1217782          DOI: 10.1042/bj3190399

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  53 in total

1.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

2.  Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa.

Authors:  B Dahlbäck; J Stenflo
Journal:  Eur J Biochem       Date:  1980-06

3.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V.

Authors:  F J Walker; P W Sexton; C T Esmon
Journal:  Biochim Biophys Acta       Date:  1979-12-07

4.  Prolonged shock in the baboon subjected to infusion of E. coli endotoxin.

Authors:  J J Coalson; B Benjamin; L T Archer; B Beller; C L Gilliam; F B Taylor; L B Hinshaw
Journal:  Circ Shock       Date:  1978

5.  Purification and characterization of human coagulation factor V.

Authors:  W H Kane; P W Majerus
Journal:  J Biol Chem       Date:  1981-01-25       Impact factor: 5.157

6.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

7.  Preparation and properties of bovine factor VIII (antihemophilic factor).

Authors:  G A Vehar; E W Davie
Journal:  Biochemistry       Date:  1980-02-05       Impact factor: 3.162

8.  Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

Authors:  W Kisiel
Journal:  J Clin Invest       Date:  1979-09       Impact factor: 14.808

9.  Activated protein C inhibits platelet prothrombin-converting activity.

Authors:  P C Comp; C T Esmon
Journal:  Blood       Date:  1979-12       Impact factor: 22.113

10.  Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

View more
  12 in total

1.  Microparticles formed during storage of red blood cell units support thrombin generation.

Authors:  Beth A Bouchard; Thomas Orfeo; Hollis N Keith; Elizabeth M Lavoie; Matthew Gissel; Mark Fung; Kenneth G Mann
Journal:  J Trauma Acute Care Surg       Date:  2018-04       Impact factor: 3.313

2.  Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity.

Authors:  Jeremy P Wood; Jay R Silveira; Nicole M Maille; Laura M Haynes; Paula B Tracy
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

3.  Inhibition of thrombin activity by prothrombin activation fragment 1.2.

Authors:  Swapan Kumar Dasgupta; Perumal Thiagarajan
Journal:  J Thromb Thrombolysis       Date:  2007-03-02       Impact factor: 2.300

Review 4.  The influence of biomaterials on endothelial cell thrombogenicity.

Authors:  Alison P McGuigan; Michael V Sefton
Journal:  Biomaterials       Date:  2007-02-09       Impact factor: 12.479

5.  Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain.

Authors:  Reto A Schuepbach; Kara Velez; Matthias Riewald
Journal:  Blood       Date:  2011-04-07       Impact factor: 22.113

6.  Enhancing the anticoagulant profile of meizothrombin.

Authors:  Bosko M Stojanovski; Leslie A Pelc; Xiaobing Zuo; Nicola Pozzi; Enrico Di Cera
Journal:  Biomol Concepts       Date:  2018-12-26

7.  Membrane binding by prothrombin mediates its constrained presentation to prothrombinase for cleavage.

Authors:  Harlan N Bradford; Steven J Orcutt; Sriram Krishnaswamy
Journal:  J Biol Chem       Date:  2013-08-12       Impact factor: 5.157

8.  Angiopoietins bind thrombomodulin and inhibit its function as a thrombin cofactor.

Authors:  Christopher Daly; Xiaozhong Qian; Carla Castanaro; Elizabeth Pasnikowski; Xiabo Jiang; Benjamin R Thomson; Susan E Quaggin; Nicholas Papadopoulos; Yang Wei; John S Rudge; Gavin Thurston; George D Yancopoulos; Samuel Davis
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

9.  Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-14       Impact factor: 8.311

10.  Cooperative regulation of the activity of factor Xa within prothrombinase by discrete amino acid regions from factor Va heavy chain.

Authors:  Melissa A Barhoover; Tivadar Orban; Michael A Bukys; Michael Kalafatis
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.